Estrogen Deficiency Impairs Osseointegration in Hypertensive Rats Even Treated with Alendronate Coated on the Implant Surface

Hypertension and estrogen deficiency can affect bone metabolism and therefore increase the risk of osseointegration. Antihypertensive drugs such as losartan not only control blood pressure but also enhance bone healing. In addition, alendronate sodium is widely used to treat postmenopausal osteoporo...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Gabriel Mulinari-Santos, Jaqueline Silva dos Santos, Igor Lebedenco Kitagawa, Fábio Roberto de Souza Batista, Paulo Roberto Botacin, Cristina Antoniali, Paulo Noronha Lisboa-Filho, Roberta Okamoto
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2023-09-01
Reeks:	Journal of Functional Biomaterials
Onderwerpen:	bone losartan osseointegration alendronate spontaneously hypertensive rats
Online toegang:	https://www.mdpi.com/2079-4983/14/9/471
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!